Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

STIM

+ Watchlist+ Portfolio

Neuronetics, Inc.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$1.28
52-Week Range
$0.80 – $3.44
Market Cap
$120.60M
P/E (TTM)
—
EPS (TTM)
-0.32
Dividend Yield
0.00%
Advanced Metrics
Price/Book
5.19
PEG Ratio
—
Return on Equity
-85.58%
Return on Assets
-6.58%
Gross Margin
50.93%
Operating Margin
-9.14%
Profit Margin
-14.45%
Current Ratio
2.01
Debt/Equity
3.92
Total Debt
$87.73M
Free Cash Flow
$-4.65M
Revenue Growth
12.50%
Earnings Growth
—
Enterprise Value
$166.48M

Market Snapshot

About

Neuronetics, Inc. is a commercial-stage medical technology company focused on non-invasive treatments for psychiatric disorders. The company develops and markets the NeuroStar Advanced Therapy system, a transcranial magnetic stimulation device for treating major depressive disorder and other mental health conditions.